NovApproach Spine Elects Sigurd H. Berven, MD, to Board

Spine Expert Supports Commercialization of New Interbody Fusion Device

NovApproach Spine, developer of the patented OneLIF™ interbody spinal fusion system, which supports a multitude of surgical approaches, announced today the election of orthopaedic surgeon Sigurd Berven, MD, to its board of managers. Berven is the chief of spine service and professor of orthopedic surgery at the University of California, San Francisco (UCSF). A member of NovApproach’s OneLIF design team, Berven was the first to use the implant in spine surgery.

NovApproach CEO Raymond Cloutier reports, “Dr. Berven has been a chief contributor to the OneLIF cage’s evolution. A world-renowned expert in treating spinal disorders, he brings clinical, research and academic perspectives that will strengthen our company’s ability to deliver clinically relevant solutions. It’s an honor to have his guidance during our company’s rapid growth.”

According to Berven, “It’s been truly rewarding to collaborate with the OneLIF design team. Since performing the first surgery with this versatile cage, I found its unique versatility particularly helpful for patients with both standard and challenging anatomic conditions. I’m proud to join NovApproach’s board as we expand adoption of OneLIF to benefit many surgeons and their patients.”

The OneLIF system offers surgeons a groundbreaking solution: a single cage that supports three distinct approaches to the patient’s lumbar spine: Anterior Lumbar Interbody Fusion (ALIF), the LateralATP™ Approach and the SupineATP® Approach. This enables surgeons to optimize their approach while the OneLIF cage’s six fixation screw options and two inserter positions offer unprecedented flexibility to address varying patient anatomies.

Dr. Berven’s journey is marked by academic excellence, including completing his studies at Stanford University and Oxford University, earning his medical degree from Harvard Medical School, and completing a spine surgery fellowship at UCSF. He is widely recognized for his expertise and frequently speaks at national and international conferences on advanced techniques in spinal surgery. Dr. Berven will share his experience with OneLIF during scheduled times at NovApproach’s educational exhibit #2507 at the 2023 North American Spine Society Annual Meeting, Oct. 18 – 21 in Los Angeles.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.